Arch Venture Fund Ix, L.p. - Net Worth and Insider Trading
Arch Venture Fund Ix, L.p. Net Worth
The estimated net worth of Arch Venture Fund Ix, L.p. is at least $265 Million dollars as of 2024-11-13. Arch Venture Fund Ix, L.p. is the 10% Owner of Vir Biotechnology Inc and owns about 28,666,663 shares of Vir Biotechnology Inc (VIR) stock worth over $265 Million. Details can be seen in Arch Venture Fund Ix, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Arch Venture Fund Ix, L.p. has not made any transactions after 2019-10-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Arch Venture Fund Ix, L.p.
Arch Venture Fund Ix, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Fund Ix, L.p. owns 6 companies in total, including Beam Therapeutics Inc (BEAM) , Vir Biotechnology Inc (VIR) , and Karuna Therapeutics Inc (KRTX) among others .
Click here to see the complete history of Arch Venture Fund Ix, L.p.’s form 4 insider trades.
Insider Ownership Summary of Arch Venture Fund Ix, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BEAM | Beam Therapeutics Inc | 2020-02-05 | 10 percent owner |
| VIR | Vir Biotechnology Inc | 2021-03-30 | 10 percent owner |
| KRTX | Karuna Therapeutics Inc | 2019-06-27 | 10 percent owner |
 | | 2019-02-07 | 10 percent owner |
| | 2021-02-03 | 10 percent owner |
| | 2021-06-16 | 10 percent owner |
Arch Venture Fund Ix, L.p. Latest Holdings Summary
Arch Venture Fund Ix, L.p. currently owns a total of 1 stock. Arch Venture Fund Ix, L.p. owns 28,666,663 shares of Vir Biotechnology Inc (VIR) as of October 16, 2019, with a value of $265 Million.
Latest Holdings of Arch Venture Fund Ix, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIR | Vir Biotechnology Inc | 2019-10-16 | 28,666,663 | 9.25 | 265,166,633 |
Holding Weightings of Arch Venture Fund Ix, L.p.
Arch Venture Fund Ix, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Arch Venture Fund Ix, L.p. has made a total of 0 transactions in Vir Biotechnology Inc (VIR) over the past 5 years. The most-recent trade in Vir Biotechnology Inc is the acquisition of 1,000,000 shares on October 16, 2019, which cost Arch Venture Fund Ix, L.p. around $20 Million.
Insider Trading History of Arch Venture Fund Ix, L.p.
- 1
Arch Venture Fund Ix, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Arch Venture Fund Ix, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arch Venture Fund Ix, L.p. is 16.01%. GuruFocus also compares Arch Venture Fund Ix, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Arch Venture Fund Ix, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arch Venture Fund Ix, L.p.'s insider trading performs compared to the benchmark.
Performance of Arch Venture Fund Ix, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -12.03 | | | | | |
| Relative Return to S&P 500(%) | -16.4 | | | | | |
Arch Venture Fund Ix, L.p. Ownership Network
Ownership Network List of Arch Venture Fund Ix, L.p.
Ownership Network Relation of Arch Venture Fund Ix, L.p.
Arch Venture Fund Ix, L.p. Owned Company Details
What does Beam Therapeutics Inc do?
Who are the key executives at Beam Therapeutics Inc?
Arch Venture Fund Ix, L.p. is the 10 percent owner of Beam Therapeutics Inc. Other key executives at Beam Therapeutics Inc include President & CSO Giuseppe Ciaramella , Chief Legal Officer Christine Bellon , and director & CEO John M. Evans .
Beam Therapeutics Inc (BEAM) Insider Trades Summary
Over the past 18 months, Arch Venture Fund Ix, L.p. made no insider transaction in Beam Therapeutics Inc (BEAM). Other recent insider transactions involving Beam Therapeutics Inc (BEAM) include a net sale of 16,081 shares made by Christine Bellon , a net sale of 263,284 shares made by Giuseppe Ciaramella , and a net sale of 198,102 shares made by John M. Evans .
In summary, during the past 3 months, insiders sold 162,894 shares of Beam Therapeutics Inc (BEAM) in total and bought 0 shares, with a net sale of 162,894 shares. During the past 18 months, 1,413,543 shares of Beam Therapeutics Inc (BEAM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413,543 shares.
Beam Therapeutics Inc (BEAM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Beam Therapeutics Inc Insider Transactions
Arch Venture Fund Ix, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Arch Venture Fund Ix, L.p.. You might contact Arch Venture Fund Ix, L.p. via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
